Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 9.35
(-0.32%)
CNY 9.35
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 254.1 Million | 686.89 Million | 597.53 Million | 258.45 Million | 239.17 Million | 204.93 Million |
| Cost of Revenue | 157.91 Million | 298.76 Million | 169.51 Million | 63.66 Million | 65.85 Million | 64.79 Million |
| Gross Profit | 96.18 Million | 388.13 Million | 428.02 Million | 194.78 Million | 173.31 Million | 140.14 Million |
| Operating Expenses | 302.17 Million | 250.43 Million | 160.08 Million | 102.24 Million | 75.41 Million | 56.18 Million |
| Selling, General and Administrative Expenses | 80.51 Million | 89.05 Million | 67.28 Million | 51.95 Million | 2.73 Million | 1.37 Million |
| Research and Development Expenses | 53.4 Million | 111.41 Million | 72.43 Million | 40.46 Million | 33.68 Million | 24.42 Million |
| Other Expenses | 196.31 Million | -3.22 Million | -237.54 Thousand | -1.16 Million | -2.12 Million | -2.2 Million |
| Cost and Expenses | 428.83 Million | 549.19 Million | 329.59 Million | 165.91 Million | 141.27 Million | 120.97 Million |
| Operating Income | -115.17 Million | 98.1 Million | 268.27 Million | 75.1 Million | 105.23 Million | 84.79 Million |
| Interest Expense | 10.79 Million | 4.08 Million | 2.37 Million | 369.73 Thousand | 56.88 Thousand | 76.85 Thousand |
| Income Tax Expense | 7.18 Million | 12.22 Million | 31.56 Million | 8.49 Million | 13.74 Million | 10.76 Million |
| Earnings before Tax | -122.92 Million | 94.88 Million | 268.03 Million | 73.94 Million | 106.03 Million | 84.67 Million |
| Net Income | -184.9 Million | 82.96 Million | 236.5 Million | 65.44 Million | 92.3 Million | 73.93 Million |
| Earnings Per Share Basic | -0.46 | 0.21 | 0.59 | 0.16 | 0.23 | 0.75 |
| Earnings Per Share Diluted | -0.46 | 0.21 | 0.59 | 0.16 | 0.23 | 0.75 |
| Weighted Average Shares Outstanding | 401.97 Million | 400.86 Million | 400.86 Million | 400.86 Million | 400.86 Million | 98.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 401.97 Million | 400.86 Million | 400.86 Million | 400.86 Million | 400.86 Million | 98.58 Million |
| Gross Margin | 0.38 | 0.57 | 0.72 | 0.75 | 0.72 | 0.68 |
| EBIT Margin | -0.53 | 0.26 | 0.49 | 0.37 | 0.45 | 0.43 |
| Profit Margin | -0.73 | 0.12 | 0.40 | 0.25 | 0.39 | 0.36 |
| EBITDA | -133.69 Million | 129.33 Million | 300.86 Million | 79.82 Million | 113.43 Million | 91.62 Million |
| Earnings Before Tax Margin | -0.45 | 0.14 | 0.45 | 0.29 | 0.44 | 0.41 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 66.99 Million | 36.37 Million | 254.1 Million | 89 Million | 52.98 Million | 51.4 Million |
| Cost of Revenue | 26.32 Million | 9.25 Million | 127.23 Million | 42.58 Million | 16.61 Million | 22.5 Million |
| Gross Profit | 40.66 Million | 27.11 Million | 126.87 Million | 46.41 Million | 36.37 Million | 28.89 Million |
| Operating Expenses | 36.56 Million | 32.23 Million | 193.72 Million | 36.48 Million | 36.93 Million | 72.9 Million |
| Selling, General and Administrative Expenses | 28.37 Million | 21.95 Million | - | -34.02 Million | 48.03 Million | 35.9 Million |
| Research and Development Expenses | 8.18 Million | 10.28 Million | - | 4.53 Million | 8.1 Million | 22.11 Million |
| Other Expenses | -84.15 Thousand | 12.65 Thousand | -2.49 Million | -1.34 Million | -950.37 Thousand | -292.91 Thousand |
| Cost and Expenses | 62.89 Million | 41.49 Million | 320.96 Million | 79.07 Million | 53.55 Million | 95.4 Million |
| Operating Income | 4.1 Million | -5.12 Million | -175.3 Million | -80.21 Million | -11.29 Million | -50.25 Million |
| Interest Expense | 2.88 Million | 5.39 Million | 10.62 Million | 6.12 Million | 961.36 Thousand | 2.35 Million |
| Income Tax Expense | 770.86 Thousand | -55.96 Thousand | 7.18 Million | 4.2 Million | 17.29 Million | -8.96 Million |
| Earnings before Tax | 8.17 Million | -5.17 Million | -177.79 Million | -81.55 Million | -12.24 Million | -50.55 Million |
| Net Income | 5.55 Million | -7.11 Million | -184.9 Million | -85.74 Million | -29.52 Million | -41.57 Million |
| Earnings Per Share Basic | 0.01 | -0.02 | - | -0.22 | -0.07 | -0.10 |
| Earnings Per Share Diluted | 0.01 | -0.02 | - | -0.22 | -0.07 | -0.10 |
| Weighted Average Shares Outstanding | 400.86 Million | 400.86 Million | 401.97 Million | 394.35 Million | 400.86 Million | 400.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 400.86 Million | 400.86 Million | 401.97 Million | 394.35 Million | 400.86 Million | 400.86 Million |
| Gross Margin | 0.61 | 0.75 | 0.50 | 0.52 | 0.69 | 0.56 |
| EBIT Margin | 0.17 | -0.08 | - | -0.39 | -0.10 | -0.70 |
| Profit Margin | 0.08 | -0.20 | -0.73 | -0.96 | -0.56 | -0.81 |
| EBITDA | 11.2 Million | -2.74 Million | - | -35.11 Million | -5.18 Million | -35.74 Million |
| Earnings Before Tax Margin | 0.06 | -0.14 | -0.69 | -0.90 | -0.21 | -0.98 |
REGRF
QOMO
QOMOW
KGKC
000892
BACA